These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6373454)

  • 1. Insulin resistance in Cushing's disease. Evaluation by studies of insulin binding to erythrocytes.
    Wajchenberg BL; Leme CE; Lerario AC; Toledo e Souza IT; Rodbard HW; Rodbard D
    Diabetes; 1984 May; 33(5):455-9. PubMed ID: 6373454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in Cushing's syndrome.
    Karnieli E; Cohen P; Barzilai N; Ish-Shalom Z; Armoni M; Rafaelov R; Barzilai D
    Horm Metab Res; 1985 Oct; 17(10):518-21. PubMed ID: 3905556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin-receptor interaction in Cushing's syndrome].
    Pallardo Sánchez LF; Grande Aragón C; López López J; Guerrero Martínez E; Albero Gamboa R; Cerdán Vallejo A
    Rev Clin Esp; 1986 Jun; 179(1):18-21. PubMed ID: 3526431
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of glucocorticoid on 125I-insulin binding to human erythrocytes. Possible postreceptor modulation of receptor binding.
    Lee KU; Kim SY; Lee HK; Min HK
    Diabetes Res Clin Pract; 1985 Dec; 1(4):211-20. PubMed ID: 3915263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
    Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in Cushing's syndrome.
    Nosadini R; Del Prato S; Tiengo A; Valerio A; Muggeo M; Opocher G; Mantero F; Duner E; Marescotti C; Mollo F; Belloni F
    J Clin Endocrinol Metab; 1983 Sep; 57(3):529-36. PubMed ID: 6348064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased insulin binding of erythrocytes and insulin sensitivity in adrenal insufficiency.
    Takeda N; Yasuda K; Kitabchi AE; Horiya T; Jallepalli P; Miura K
    Metabolism; 1987 Nov; 36(11):1063-6. PubMed ID: 3312935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
    Page R; Boolell M; Kalfas A; Sawyer S; Pestell R; Ward G; Alford F
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):509-17. PubMed ID: 1769133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
    Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptors on monocytes and erythrocytes from obese patients.
    De Pirro R; Fusco A; Lauro R; Testa I; Ferretti G; De Martinis C
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1437-9. PubMed ID: 7002953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome: a model for sarcopenic obesity.
    Drey M; Berr CM; Reincke M; Fazel J; Seissler J; Schopohl J; Bidlingmaier M; Zopp S; Reisch N; Beuschlein F; Osswald A; Schmidmaier R
    Endocrine; 2017 Sep; 57(3):481-485. PubMed ID: 28702888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period.
    García-Estévez DA; Araújo-Vilar D; Cabezas-Cerrato J
    Diabetes Res Clin Pract; 1998 Feb; 39(2):107-13. PubMed ID: 9597380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte insulin binding in obese children and adolescents.
    Kappy MS; Plotnick L
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1440-6. PubMed ID: 7002954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN; Peterson ME; Drucker WD
    Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo insulin sensitivity and insulin binding to erythrocytes in children: insulin resistance in obese children.
    Asayama K; Amemiya S; Kato K; Shimizu M
    Endocrinol Jpn; 1982 Oct; 29(5):575-81. PubMed ID: 6133745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
    Pirich K; Vierhapper H
    Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased insulin binding and antilipolytic response in adipocytes from patients with Cushing's syndrome.
    Calle C; Carranza MC; Simón MA; Torres A; Mayor P
    Biosci Rep; 1987 Sep; 7(9):713-9. PubMed ID: 3322423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease.
    Faggiano A; Pivonello R; Melis D; Alfieri R; Filippella M; Spagnuolo G; Salvatore F; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Feb; 25(2):142-51. PubMed ID: 11929085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.